New hope for GBS: Single-Dose drug enters final testing
NCT ID NCT07020819
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single dose of tanruprubart (ANX005) in 30 adults and children with Guillain-Barré syndrome (GBS), a rare nerve disorder that causes weakness. The goal is to see how the drug works in the body, its early effects, and its safety. Participants must have GBS symptoms for 10 days or less and have not received standard treatments like plasma exchange or IV immunoglobulin.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GUILLAIN-BARRE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Aarhus University Hospital
RECRUITINGAarhus, Aarhus N, 8200, Denmark
-
Children's Hospital of Orange County
RECRUITINGOrange, California, 92868, United States
-
Henry Ford Health
RECRUITINGDetroit, Michigan, 48202, United States
-
HonorHealth Bob Bové Neuroscience Institute
RECRUITINGScottsdale, Arizona, 85251, United States
-
Mayo Clinic Florida
RECRUITINGJacksonville, Florida, 32224, United States
-
Mayo Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Ochsner LSU Health
RECRUITINGShreveport, Louisiana, 71101, United States
-
Profound Research LLC
RECRUITINGCarlsbad, California, 92011, United States
-
St. Joseph's Hospital & Medical Center - Barrow Neurological Institute
RECRUITINGPhoenix, Arizona, 85013, United States
-
University Massachusetts Chan Medical School
RECRUITINGWorcester, Massachusetts, 01655, United States
-
University of California Irvine
RECRUITINGOrange, California, 92868, United States
-
University of Colorado Hospital
RECRUITINGAurora, Colorado, 80045, United States
-
University of Kansas Medical Center
RECRUITINGKansas City, Kansas, 66160, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.